U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 9-15, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 9-15, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 01/09/2022
Location: Virtual
Subject: 2022 Innovations in Regulatory Science Summit - Movers and Shapers: The Future of Drug and Device Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, and other registered guests

Event Date: 01/13/2022
Location: Virtual
Subject: Real: Health Equity 2022 - The FDA's Perspective on Advancing Health Equity
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other registered guests

Event Date: 01/14/2022
Location: Virtual
Subject: Advanced Manufacturing and Other Related Topics
FDA Participant/Group: N/A
Non FDA Participant/Group: Mark McClellan (Duke University);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/11/2022
Location: Virtual
Subject: Association of Food and Drug Officials Foodborne Illness Reduction via Healthy People 2030 Meeting; Keynote Speech: Bending the Curve of Foodborne Illness
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members and scientific experts from the food industry, academia, associations, and state and federal government organizations

Event Date: 01/13/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Event Date: 01/14/2022
Location: Virtual
Subject: Poppy Seed Issues of Mutual Interest
FDA Participant/Group: CONRAD CHOINIERE; DOUGLAS STEARN; JANESIA ROBBS;
Non FDA Participant/Group: James Kincheloe, Sarah Sorscher (Center for Science in the Public Interest); Betty Hacala, Steve Hacala

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 01/10/2022
Location: Virtual
Subject: Access to Covid-19 Vaccines and Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Tahir Amin (Initiatives for Medicines, Access,and Knowledge (I-MAK));

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/10/2022
Location: Virtual
Subject: COVID-19 Therapeutic Emergency Use Authorizations
FDA Participant/Group: JOHN FARLEY;
Non FDA Participant/Group: Participants from industry, academia, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/14/2022
Location: Virtual
Subject: 25th Annual F. Robert Fekety, Jr., MD, Lecture; Facilitating the Development of COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 25th Annual F. Robert Fekety, Jr., MD, Lecture

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 01/11/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: ANNE NORRIS; KATHERINE HUEBNER; NADINE STEINBERG; CHARLI LONG; AMBER MCCOIG; LESLIE KENNA; MATTHEW LUCIA; ERROL STRAIN; CINDY BURNSTEEL; HEATHER TATE; ANTONIA MONIQUE SENNETT; PATRICK MCDERMOTT; JOSHUA HAYES; TIMOTHY SCHELL; NEAL BATALLER; WILLIAM FLYNN; JOHN MUSSMAN; ASHLEY STEEL; JULI ANN PUTNAM; SIOBHAN DELANCEY; REGINA TAN; JEFFREY GILBERT;
Non FDA Participant/Group: Representatives of Keep Antibiotics Working (KAW)

Event Date: 01/13/2022
Location: Virtual
Subject: Animal Drug User Fee Act (ADUFA) Stakeholder Public Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, government, and other stakeholders

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top